T
TENX
Tenax Therapeutics Inc
15.02
-0.99-6.16%After Hours: 15.02 +0.01 +0.03%17:53 04/02 EDT
OPEN/PREV CLOSE15.68/16.00
TODAY RANGE14.80-15.98
VOL335.12K
MARKET CAP258.22M
52 WEEK RANGE4.630-18.38
AVG VOL (3M)341.60K
% TURNOVER1.95%
TURNOVER--
P/E (TTM)-11.1952
% RANGE6.84%
EPS(TTM)-1.3412
P/E(FORWARD)0.0002
P/B1.441
BVPS10.42
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP86.87M
SHARES OUTSTANDING17.20M
NEXT EARNINGS05/12-05/18
FREE FLOAT5.79M
LOT SIZE1
EX-DATE01/03/2024
News
Press Releases
Financial Reports
Profile
NASDAQ·03/27 03:14
Tenax Therapeutics (TENX) Price Target Increased by 13.86% to 29.32
TipRanks·03/25 12:38
Four new option listings on March 25th
TipRanks·03/24 15:45
Tenax Therapeutics files $300M mixed securities shelf
Benzinga·03/24 15:44
Tenax Therapeutics Files Prospectus For Offering $300M Securities
Reuters·03/24 15:42
TENAX THERAPEUTICS INC - MAY OFFER UP TO $300 MLN OF SECURITIES - SEC FILING
Seeking Alpha·03/18 16:06
Tenax Therapeutics: A Binary Bet With Heavy Downside Likely
Seeking Alpha·03/17 15:57
Tenax wins bullish view at Cantor ahead of pivotal readout
TipRanks·03/17 13:36
DraftKings, Eli Lilly downgraded: Wall Street’s top analyst calls
Dow Jones·03/17 12:50
Tenax Therapeutics Initiated at Overweight by Cantor Fitzgerald
Dow Jones·03/17 12:50
Tenax Therapeutics Price Target Announced at $35.00/Share by Cantor Fitzgerald
Benzinga·03/17 12:45
This Ingredion Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
TipRanks·03/17 11:31
Cantor starts Tenax at Overweight into Phase 3 readout
TipRanks·03/17 10:10
Tenax Therapeutics initiated with an Overweight at Cantor Fitzgerald
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.